A proposal to strip Australians aged 65 and over of their higher private health insurance rebate is drawing new attention to a narrower but high-cost exposure for insurers: cataract surgery and optical extras benefits, which make up a disproportionate share of claims among older policyholders.
Private Healthcare Australia (PHA), the peak body representing 21 health funds, told a Senate inquiry in June that the rebate change would leave three million Australians aged 65 and over facing higher costs to access optometry care, eye surgery and other health services. The submission estimated the change would cause 62,000 people to drop their cover and 200,000 to downgrade next year, cutting against the same pool of policyholders who generate the bulk of cataract and eye-surgery claims volume.
Cataract removal is one of the most common procedures funded through private hospital cover, and PHA's submission put a figure on how concentrated that exposure is: private health insurance contributed $11.8 billion toward 2.8 million hospital visits for Australians aged 65 and over last year, with about 67% of planned surgery, including cataract removals, taking place in the private sector. PHA chief executive Dr. Rachel David said losing this cohort's cover would strip away more than hospital access alone, warning that coverage for allied health services will be one of the first things to go.
That claim carries direct relevance for extras and optical benefit design. Under the Medicare Benefits Schedule item for standard cataract surgery, the government rebate covers 75% of the scheduled fee, currently $910.35 as of the July 1, 2026 update, leaving a gap of roughly $227.55 before any surgeon excess – a gap typically absorbed by hospital cover. If older policyholders downgrade to exclude eye procedures or drop cover altogether to manage premium increases, insurers face a smaller, more price-sensitive pool covering the same fixed-cost surgical exposure.
The urgency PHA attaches to maintaining private access is corroborated independently of the insurer submission. Melbourne ophthalmologist Dr. Ross MacIntyre, a Fellow of the Royal Australian and New Zealand College of Ophthalmologists, has noted that public hospital waiting lists for cataract surgery in Melbourne can extend beyond 12 months, compared with typical private access within weeks. That gap matters for insurers weighing product design, since a policyholder base shifting toward downgraded or exited cover does not remove demand for the procedure – it defers it into a public system already carrying long queues, a dynamic PHA also raised in its submission, projecting the changes could add $260 million a year to state and territory hospital budgets.
PHA's submission to the Senate inquiry proposed targeting the rebate reduction toward higher-income retirees rather than removing it across the board, alongside lowering the cost of private medical devices and raising the Medicare Levy Surcharge for higher earners who forgo hospital cover. Dr. David said the sector needs assurance that older Australians who have sacrificed to pay for health insurance for decades can continue to access private healthcare when they need it.
For insurers and brokers managing books with a high concentration of older policyholders, the immediate planning question is not whether the rebate bill passes, but how exposed cataract and optical extras benefits are if a meaningful share of that cohort downgrades before the proposed April 2027 start date. Product teams pricing 2027 premiums will need to weigh retention risk in hospital tiers that include eye surgery against the fixed-cost nature of cataract claims, which do not disappear when a policyholder exits — they migrate to the public system, or go untreated.
The Senate Community Affairs Legislation Committee's report on the bill is due by October 7, which will determine whether the rebate change proceeds toward a vote.
